Browse verified doctors or let our care team help you find the doctor best suited to your condition, treatment goals, and budget.
Bangkok Hospital offers specialised Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern surgical and medical oncology technologies and established treatment protocols. Established in 1972, the JCI accredited hospital is situated in Bangkok, Thailand, with 580 beds, serving local and international patients.
Treatment may include surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, or biliary drainage procedures, depending on the cancer's location and stage. Molecular testing may identify specific alterations that could make targeted treatment appropriate. Before therapy, specialists conduct comprehensive imaging, pathology, staging, and liver-function assessments to develop an individualised treatment plan.
Vejthani Hospital provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 1994, the JCI accredited hospital is based in Bangkok, Thailand, with 263 beds and services for domestic and international patients.
The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.
At Bangpakok 9 International Hospital, patients can access comprehensive Cholangiocarcinoma Treatment supported by advanced diagnostic, surgical, and oncology facilities. Established in 2003, the JCI, GHA accredited hospital is located in Bangkok, Thailand, and has 300 beds.
Bile duct cancer treatment is personalised according to the tumour's location, stage, and overall health of the patient. Potentially operable tumours may be treated with surgery, while patients with advanced disease may receive systemic therapies such as chemotherapy, targeted medicines, or immunotherapy. Biliary drainage or stenting may also be used to relieve obstruction when required.
Phyathai 2 International Hospital offers specialised Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern surgical and medical oncology technologies and established treatment protocols. Established in 1987, the JCI accredited hospital is situated in Bangkok, Thailand, with 550 beds, serving local and international patients.
Treatment may include surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, or biliary drainage procedures, depending on the cancer's location and stage. Molecular testing may identify specific alterations that could make targeted treatment appropriate. Before therapy, specialists conduct comprehensive imaging, pathology, staging, and liver-function assessments to develop an individualised treatment plan.
Krabi Nakharin International Hospital offers specialised Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern surgical and medical oncology technologies and established treatment protocols. Established in 1997, the JCI accredited hospital is situated in Krabi, Thailand, with 150 beds, serving local and international patients.
Treatment may include surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, or biliary drainage procedures, depending on the cancer's location and stage. Molecular testing may identify specific alterations that could make targeted treatment appropriate. Before therapy, specialists conduct comprehensive imaging, pathology, staging, and liver-function assessments to develop an individualised treatment plan.
Yanhee International Hospital offers advanced Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern oncology and hepatobiliary surgery techniques and internationally accepted treatment protocols. Established in 1984, the ISO, JCI accredited hospital is located in Bangkok, Thailand, with 400 beds, providing comprehensive cancer care for local and international patients.
Treatment depends on the location, stage, and extent of the bile duct cancer. Surgery may be considered for tumours that can be completely removed, while advanced disease may require chemotherapy, targeted therapy, immunotherapy, or radiation therapy. Detailed imaging, tissue diagnosis, and molecular testing may help specialists determine the most appropriate treatment approach.
Sikarin Hospital provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 1979, the JCI accredited hospital is based in Bangkok, Thailand, with 354 beds and services for domestic and international patients.
The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.
Kasemrad Ramkhamhaeng Hospital provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 1992, the JCI accredited hospital is based in Bangkok, Thailand, with 120 beds and services for domestic and international patients.
The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.
Piyavate Hospital offers advanced Cholangiocarcinoma (Bile Duct Cancer) Treatment using modern oncology and hepatobiliary surgery techniques and internationally accepted treatment protocols. Established in 1993, the JCI, ISO accredited hospital is located in Bangkok, Thailand, with 150 beds, providing comprehensive cancer care for local and international patients.
Treatment depends on the location, stage, and extent of the bile duct cancer. Surgery may be considered for tumours that can be completely removed, while advanced disease may require chemotherapy, targeted therapy, immunotherapy, or radiation therapy. Detailed imaging, tissue diagnosis, and molecular testing may help specialists determine the most appropriate treatment approach.
At MALI Interdisciplinary Hospital, patients can access comprehensive Cholangiocarcinoma Treatment supported by advanced diagnostic, surgical, and oncology facilities. Established in 2021, the NABH, JCI, CBAHI, AACI accredited hospital is located in Bangkok, Thailand, and has 100 beds.
Bile duct cancer treatment is personalised according to the tumour's location, stage, and overall health of the patient. Potentially operable tumours may be treated with surgery, while patients with advanced disease may receive systemic therapies such as chemotherapy, targeted medicines, or immunotherapy. Biliary drainage or stenting may also be used to relieve obstruction when required.
HE Clinic provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 2013, the NABH accredited hospital is based in Bangkok, Thailand, with beds and services for domestic and international patients.
The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.
Monica from Ghana suffered from AV malformation. She decided to look for options for medical treatment when she started experiencing episodes of unconsciousness. After a…
Nasrin (Sister of the patient ) explains the journey of how MediGence helped for the treatment of Silim Shabani for Ovarian Cancer Treatment in Turkey.
